Home › Myelodysplastic Syndromes › New Hampshire
Myelodysplastic Syndromes clinical trials in New Hampshire
5 studies for Myelodysplastic Syndromes are looking for participants at sites in New Hampshire.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT05564390Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06577441The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RecruitingPhase 1/2
Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Dartmouth-Hitchcock, Lebanon
RecruitingObservational study
Up to age 30 · All sexes · Updated Jul 16, 2026 · NCT04968834Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- Dana Farber/New Hampshire Oncology-Hematology, Londonderry
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT02269592From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.